Full Programme

• Session 1. Radiobiology and tumour biology

  DMRTA2: a promising biomarker influencing glioblastoma vascularization - Patrycja Puszko (University of Warsaw)

  Preptin as a metabolic sensor: a novel regulator of steroidogenesis in adrenocortical carcinoma - Anna Olechnowicz (Poznan University of Medical Sciences)

• Session 2. Radiation genetics and transcriptomics

  Precise mapping of m⁶a in rna using the 4sedtpp method - Julia Pestka (Adam Mickiewicz University Poznań)

  Hypoxia-induced modulation of RNA methylation in head and neck cancer: in vitro gene expression profiling - Julia Kozikowska (Poznan University of Medical Sciences)

• Session 3. Microenvironment, tumour immunology and response to radiation

  Genetically engineered M1 macrophages secreting IL-12 represent a promising approach in cancer therapy - Dorota Sprus-Lipka (Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch)

  It’s all about the neighborhood. The secrets of bone marrow stroma-leukemia communication and its pro-leukemic impact - Laura Turos-Korgul (Nencki Institute of Experimental Biology PAS)

Coffee break & time for sponsors

• Session 1. Biomarkers, diagnostics and nuclear medicine

  Two m⁶A RNA methylation writers, RBM15 and RBM15B, have been identified as drivers of Prostate Cancer progression - Klaudia Detkiewicz (Lund University)

  Targeting REST and KAISO: A Promising Approach for Glioblastoma Treatment - Zuzanna Bieńkowska (University of Warsaw)

• Session 2. Radiation effect of modifiers and systematic treatment

  Proactive therapy of acute radiation-induced skin injury (aRISI) in head and neck cancer – preliminary results - Paweł Głuszak (Poznan University of Medical Sciences)

  Evaluation of the effectiveness of hypofractionated radiotherapy with curative intent in the treatment of elderly or frail patients with oropharyngeal cancer - Karol Paciorek (Maria Skłodowska-Curie National Research Institute of Oncology)

• Session 3. New trends in clinics

  The Role of Biotin and Biotinylated Nanocarriers in Targeted Cancer Therapy: Preclinical Insights - Magdalena Twardowska (Rzeszow University of Technology)

  METTL3 Depletion Alters the Transcriptomic Landscape and Chemotherapy Response in Head and Neck Squamous Cell Carcinoma Cells - Kamila Ostrowska (Poznan University of Medical Sciences)

Lunch & time for sponsors

• Session 1. Low doses and their effects

  Balancing dose and image quality in 3d igrt: a phantom study with mosfet detectors - Kinga Graczyk (Greater Poland Cancer Centre)

  Impact of VMAT Treatment Plan Complexity on Patient-Specific QA (PSQA) Outcomes in Prostate Cancer Radiotherapy - Paulina Jasiewicz (Greater Poland Cancer Centre)

• Session 2. New trends in physics

  Electrochemical determination of the three-factor problem: SWV study of the interaction between diadenosine triphosphate, S-allylcysteine, and dsDNA - Oskar Szczepaniak (Poznań University of Life Sciences)

  The role of nucleotide excision repair system genes in head and neck cancer - Bartosz Maćkowiak (Poznan University of Medical Sciences)

Coffee break & time for sponsors

Jury deliberations

Małgorzata Blatkiewicz, PhD

Poznan University of Medical Sciences